Urology Coding Alert

Reader Question:

BTA Test

Question: How should we bill for the bladder tumor antigen (BTA) stat test?

South Carolina Subscriber

Answer: Now called the Bard stat test, this is an in-office bladder detection test that is coded 86294 (immunoassay for tumor antigen, qualitative or semiquantitative [e.g., bladder tumor antigen]). This is a new code for 2001. Prior to this year, BTA was reported under 86316 (immunoassay for tumor antigen; other antigen, quantitative [e.g., CA 50, 72-4, 549], each). You will only be paid for this code when the patient has a known bladder tumor history (V10.51), a present tumor (188.x) or carcinoma of the bladder (233.7). It will not be paid when used as a screening test.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Which Codify by AAPC tool is right for you?

Call 844-334-2816 to speak with a Codify by AAPC specialist now.